Amid a rapidly evolving landscape in the treatment of muscle-invasive bladder cancer (MIBC), new findings presented at the ...
According to investigators, there is no validated PSA-based endpoint to compare oncologic outcomes after radical prostatectomy and radiation therapy for localized prostate cancer.
Nadofaragene firadenovec appears effective in real-world patients with bacillus Calmette-Guérin (BCG)-unresponsive nonmuscle-invasive bladder cancer ...
Real-world data support trial data on the use of lutetium-177 PSMA-617 in patients with PSMA-positive, metastatic castration-resistant prostate cancer.
The proportion of oncologists who were satisfied with their work-life integration decreased from 35% in 2013 to 24% in 2023. Burnout in US oncologists has increased over the past 10 years ...
The Food and Drug Administration (FDA) has approved Emblaveoâ„¢ (aztreonam and avibactam), in combination with metronidazole, for patients 18 years and older who have limited or no alternative ...
PSA doubling time is an essential criterion for high-risk biochemically recurrent prostate cancer that should prompt treatment escalation.
“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...
(HealthDay News) — Surgeons at Massachusetts General Hospital have successfully performed the fourth pig kidney transplant in the US. The recipient of the genetically modified pig organ was a 66 ...
Proposed changes to HIPAA regulations are meant to strengthen cybersecurity protections for electronic protected health information.
Opioid prescriptions in the emergency department linked to small increases in hospital admission and subsequent opioid prescription use. (HealthDay News) — Emergency department opioid ...
Pain intensity linked to increased likelihood of using cigarettes, e-cigarettes, cannabis, lower likelihood of alcohol use. (HealthDay News) — Among cancer survivors, pain is associated with an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results